Advances in colon cancer.
From May 29 to June 5, 2003, the American Society of Clinical Oncology held its 39th Annual Meeting in Chicago, Illinois, U.S.A. The meeting was devoted to the presentation of advances in clinical sciences, diagnosis, prevention and management of malignant disorders, and brings together investigators, clinicians, policy makers and other professionals interested in the science and impact of cancer worldwide. This report will be presented in two parts, the first focusing of colon cancer, and the second on breast cancer will be published in the next issue of Drug News & Perspectives.
Levin
Mark
M
Division of Hematology and Oncology, Lincoln Medical and Mental Health Center, 234 Eugenio Mario de Hostos Boulevard, Bronx, NY 10451, USA. MLevinmd@aol.com
D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D004338:Drug Combinations; D005472:Fluorouracil / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D000077146:Irinotecan; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011725:Pyridines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016896:Treatment Outcome
D004338:Drug Combinations; D009944:Organoplatinum Compounds; D011725:Pyridines; C431073:oxiplatin; D000077146:Irinotecan; D005472:Fluorouracil; D002166:Camptothecin